Navigation Links
Approval of Safer Alternative to Pradaxa Delayed by FDA
Date:6/26/2012

Dallas, TX (PRWEB) June 26, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who have suffered internal bleeding after taking the drug Pradaxa that the release of a safer alternative to the drug has been delayed by an FDA decision.

For now, anyone who has suffered internal bleeding after taking Pradaxa is encouraged to speak with their doctor about their options and to a lawyer about their legal rights as soon as possible.

Pradaxa is an anticoagulant medication prescribed to patients with atrial fibrillation in order to prevent strokes. The Wall Street Journal reported on April 24, 2012, that the drug already reached the $1 billion blockbuster sales mark for the 12-month period ending in February.

Unfortunately, several reports have identified risks with the drug. The FDA warned on December 7, 2011 that it was looking into the safety of Pradaxa after receiving higher than expected reports of injury or death. Most recently, the Institute for Safe Medication Practices reported on June 6, 2012 that Pradaxa led all other medications in 2011 for number of death and bleeding reports to the FDA.

Now, Reuters has reported on June 25th that the FDA is delaying the approval of Eliquis, a rival anticoagulant to Pradaxa developed by Bristol-Myers Squibb Co and Pfizer Inc. According to the article, the new drug will be marketed as a safer alternative to Warfarin since many cardiologists are no longer comfortable prescribing Pradaxa.

Due to the number of people affected by Pradaxa internal bleeding, lawyers have asked that the large number of expected lawsuits be consolidated into one central federal court. The Pradaxa lawsuit is known as Case MDL No. 2385 IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

The Pradaxa Resource Center believes that the consolidation of Pradaxa lawsuits into one court will expedite the litigation process and help victims share in valuable evidence. However, due to the specialized nature of these federal MDL cases, only certain lawyers can help.

Anyone affected by Pradaxa side effects is urged to speak with a lawyer about their legal options. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, pradaxa side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

Read the full story at http://www.prweb.com/releases/pradaxa/bleeding-lawsuits/prweb9640132.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. U.S. Bests Canada, Europe in Drug Approvals
2. Tafamidis: Approval denotes proven added benefit
3. Human factors researcher pushes for safer gas fireplaces
4. Safer Grilling Methods Might Cut Cancer Risk
5. Planting the right messages may make farms safer
6. OHSU Oregon National Primate Research Center develops new, safer method for making vaccines
7. Safer kidney cancer surgery under-used for poorer, sicker Medicare, Medicaid patients
8. Less-Invasive Surgery for Esophageal Cancer Might Be Safer
9. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
10. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... As health professionals ... known as “patient engagement.” The patient is doing more than filling out a survey; ... , “There is an increasing emphasis in health care and research on the importance ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
Breaking Medicine Technology: